Medical/Pharmaceuticals
As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, ACM-001 booster vaccine administered to first subject in phase 1 safety and immunogenicity trial
SINGAPORE and BASEL, Switzerland and SYDNEY, July 29, 2022 /PRNewswire/ -- ACM
Biolabs
2022-07-29 16:00
2060
Lynk Pharmaceuticals Announces the First Participant Dosed in Phase I Trial of LNK01004
HANGZHOU, China, July 29, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has completed dosing the first participant in the phase I clinical study inChina for its self-developed, in...
2022-07-29 10:00
3226
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SINGAPORE, July 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first g...
2022-07-29 09:24
3452
Lenstec SBL-3 multifocal intraocular lens for cataract surgery approved by FDA for sale in the US
Lenstec Inc. has announced that its SBL-3 IOL has been approved by the FDA. ST. PETERSBURG, Fla., July 29, 2022 /PRNewswire/ -- The Lenstec SBL-3 IOL (Segmented Bifocal Lens) is a next-generation asymmetric multifocal refractive IOL which provides patients with near, intermediate and distance vis...
2022-07-29 05:43
1998
ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets
NEWARK, Del., July 28, 2022 /PRNewswire/ -- ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market. Used for the preparation of...
2022-07-28 20:00
2131
Kira Pharmaceuticals Receives FDA Orphan Drug Designation for KP104, a Bifunctional Antibody Fusion Protein, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
CAMBRIDGE, Mass. and SUZHOU, China, July 28, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Or...
2022-07-28 19:00
1950
The Clinician and Clalit Health Services partner to drive value-based care and digital care pathway implementation in Israel
AUCKLAND, New Zealand and TEL AVIV, Israel, July 28, 2022 /PRNewswire/ -- The
Clinician
2022-07-28 12:33
2011
Transcenta to Present Interim Safety and Efficacy Data of the TST001 and Chemotherapy Combination Expansion Cohort for Claudin18.2 Positive First Line Gastric Cancer at ESMO Congress 2022
SUZHOU, China, July 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the interim safe...
2022-07-28 08:00
1842
Clarius Applauded by Frost & Sullivan with 2022 North American Portable Ultrasound Technology Innovation Leadership Award for Enabling High-Quality and More Affordable Ultrasound Imaging With its HD3 App-Based Scanners
The Clarius HD3 App-Based Ultrasound Scanners accurately recognize different structures in the human torso during the scanning process and auto adjusts settings to optimize imaging. SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Recently Frost & Sullivan analyzed the North American portable ultrasou...
2022-07-27 23:17
2390
BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging
Telix and BAMF Health use Illuccix® (kit for the preparation of Gallium Ga 68 gozetotide injection) for the first time with uEXPLORER® total-body PET scanner for prostate cancer imaging GRAND RAPIDS, Mich. and INDIANAPOLIS, July 27, 2022 /PRNewswire/ -- The PSMA-PET[1] imaging agent Illuccix® fr...
2022-07-27 20:30
2225
NCCN Publishes New Patient Guidelines for Breast Cancer Screening and Diagnosis Emphasizing Annual Mammograms for All Average-Risk Women Over 40
The free evidence-based, expert consensus resource, available at NCCN.org/patientguidelines, helps people ask the right questions about when and how often to screen. PLYMOUTH MEETING, Pa., July 27, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Gu...
2022-07-27 20:07
1836
Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific and Offering Customer Value with Its Advanced Gateway to Asia Services
The Gateway to Asia initiative ensures quality and timely delivery through shorter lead times, temperature and humidity control, and streamlined urgent order processing SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Based on its recent analysis of the pharmaceutical supply chain contract services in...
2022-07-27 14:03
1608
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants
Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously demonstrated with all variants of concern to date The amubarvimab/romlusevimab combination is commercially available in China and is under rev...
2022-07-27 07:00
2801
EDAN Launches Next-Gen ABG Solutions for the Clinic During 2022 AACC
A lightweight POC CO-oximetry blood gas and chemistry system i20 reveals how
photoluminescence biosensor coupled with microfluidics could transform the
future of ABG tests in clinical departments.
CHICAGO, July 26, 2022 /PRNewswire/ -- EDAN Instruments, Inc.
2022-07-26 23:47
2317
Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance
JAKARTA, Indonesia, July 26, 2022 /PRNewswire/ -- Centrient Pharmaceuticals, a global business-to-business leader in sustainable, enzymatic antibiotics manufacturing, in partnership with Menjangan Sakti, a trader of pharmaceutical raw materials inIndonesia, organized a workshop on 'Sustainability...
2022-07-26 21:45
1957
ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW
Company receives top customer rating in the 2022 IMV ServiceTrak™ Awards SAN DIEGO, July 26, 2022 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary,Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and service...
2022-07-26 21:35
1915
Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America
The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo inChicago. CHICAGO, July 26, 2022 /PRNewswire/ -- Menarini Silicon Biosystems Inc, a US...
2022-07-26 21:00
1731
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
SINGAPORE, July 26, 2022 /PRNewswire/ -- Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus (MPXV), for research use only (RUO). The ViroKey® MPXV PCR Test allows for the prompt, in vitro detection of MPXV DNA from human skin lesion specimens. It is com...
2022-07-26 21:00
1929
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan
* Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents inJapan GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious d...
2022-07-26 20:05
2108
Henlius HANQUYOU Received TGA Approval in Australia
SHANGHAI, July 26, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner Cipla Limited ("Cipla") has received the relevant registration certificates from the Therapeutic Goods Administration ofAustralia ("TGA") for the approval of Henlius' sel...
2022-07-26 18:03
2655
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 319 media titles]
2024-05-08 14:37
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 310 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 297 media titles]
2024-05-08 16:44
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 285 media titles]
2024-05-09 11:00